Related Articles
Correlation between immune‑related adverse events and treatment efficacy of anti‑PD1 immunotherapy in patients with esophageal squamous cell carcinoma
Pretreatment levels of serum alkaline phosphatase are associated with the prognosis of patients with non‑small cell lung cancer receiving immune checkpoint inhibitors
Nivolumab‑induced cholangitis in patients with non‑small cell lung cancer: Case series and a review of literature
Efficacy and safety of Infliximab for steroid‑resistant immune‑related adverse events: A retrospective study
Thyroid dysfunction induced by immune checkpoint inhibitors and tumor progression during neoadjuvant therapy of non‑small cell lung cancer: A case report and literature review